Yield10 Bioscience to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

Rhea-AI Summary

Yield10 Bioscience announces that President and CEO Oliver Peoples, Ph.D. will present at the H.C. Wainwright 23rd Annual Global Investment Conference, taking place virtually from September 13-15, 2021. The presentation will be available from 7:00 am ET on September 13, with an option for registered investors to engage in one-on-one meetings with management. Yield10 focuses on enhancing agricultural productivity through traits discovered via its 'Trait Factory' platform, specifically targeting improved Camelina varieties for various markets.

WOBURN, Mass., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, announced today that President and CEO Oliver Peoples, Ph.D. will give a corporate presentation at the H.C. Wainwright 23^rd Annual Global Investment Conference, which is being held virtually from September 13 – 15, 2021.

Yield10 management will also be available to participate in one-on-one meetings with investors who are registered to attend the conference.

Event: H.C. Wainwright 23^rd Annual Global Investment Conference
Time: Available as of 7:00 am ET on Monday, September 13, 2021
Webcast: Click this link to view the presentation

For more information about the Company, please visit www.yield10bio.com, or follow the Company on Twitter, Facebook and LinkedIn.

About Yield10 Bioscience

Yield10 Bioscience, Inc. is an agricultural bioscience company that is using its differentiated trait gene discovery platform, the “Trait Factory”, to develop improved Camelina varieties for the production of proprietary seed products, and to discover high value genetic traits for the agriculture and food industries. Our goals are to efficiently establish a high value seed products business based on developing superior varieties of Camelina for the production of feedstock oils, nutritional oils, and PHA bioplastics, and to license our yield traits to major seed companies for commercialization in major row crops, including corn, soybean and canola. Yield10 is headquartered in Woburn, MA and has an Oilseeds Center of Excellence in Saskatoon, Canada.

(YTEN-G)

Contacts:
Yield10 Bioscience:
Lynne H. Brum, (617) 682-4693, LBrum@yield10bio.com

Investor Relations:
Bret Shapiro, (561) 479-8566, brets@coreir.com
Managing Director, CORE IR

Media Inquiries:
Eric Fischgrund, eric@fischtankpr.com
FischTank PR

 

FAQ

When is Yield10 Bioscience's presentation at the H.C. Wainwright conference?

Yield10 Bioscience's presentation will be available from 7:00 am ET on September 13, 2021.

Who is presenting for Yield10 Bioscience at the conference?

Oliver Peoples, Ph.D., President and CEO of Yield10 Bioscience, will be presenting at the conference.

What is Yield10 Bioscience's focus in the agricultural sector?

Yield10 Bioscience aims to develop improved Camelina varieties and high-value genetic traits for the agriculture and food industries.

Will investors have the opportunity to meet with Yield10 management?

Yes, Yield10 management will participate in one-on-one meetings with registered investors during the conference.

Where can I find more information about Yield10 Bioscience?

More information about Yield10 Bioscience can be found on their website at www.yield10bio.com.